Skip to main content
SupplementScience

Benefits of Boswellia

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Osteoarthritis relief — a 2020 meta-analysis (Yu et al., 7 RCTs, n=545) found boswellia significantly improved pain and function scores in knee OA patients compared to placebo
  • 5-LOX inhibition — AKBA (acetyl-11-keto-beta-boswellic acid) is a direct, non-competitive inhibitor of 5-lipoxygenase, blocking pro-inflammatory leukotriene synthesis
  • Fast onset — the Aflapin (enriched boswellia) trial (Sengupta et al., 2010, n=60) demonstrated significant pain reduction within 5-7 days of supplementation
  • GI-sparing profile — unlike NSAIDs, boswellia does not inhibit COX-1, which is protective of the gastric mucosa, making it safer for long-term use
  • IBD support — a pilot RCT (Gupta et al., 2001, n=34) found boswellia extract comparable to mesalazine for maintaining remission in ulcerative colitis

What the Research Says

Boswellia serrata has been used in Ayurvedic medicine for centuries and now has substantial clinical evidence. A 2020 meta-analysis by Yu et al. (7 RCTs, n=545) confirmed significant improvements in pain and physical function for knee osteoarthritis. The patented Aflapin extract showed particularly rapid results, with significant improvements within 5-7 days (Sengupta et al., 2010). Mechanistically, AKBA directly inhibits 5-lipoxygenase, blocking leukotriene B4 and other pro-inflammatory mediators. Early research also supports benefits for inflammatory bowel disease and asthma. Boswellia is notable for its GI-sparing profile compared to NSAIDs, making it a promising alternative for long-term inflammatory condition management.

Related Conditions

OsteoarthritisInflammationIbd
Full Boswellia Guide

References

  1. (). Effectiveness of boswellia and boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC Complementary Medicine and Therapies. DOI
  2. (). A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Research & Therapy. DOI
  3. (). Comparative efficacy and tolerability of 5-Loxin and Aflapin against osteoarthritis of the knee. International Journal of Medical Sciences. DOI